Table:
begin	end	state
1	29	non-cytoplasmic
30	50	transmembrane
51	59	cytoplasmic
60	80	transmembrane
81	91	non-cytoplasmic
92	114	transmembrane
115	119	cytoplasmic
120	138	transmembrane
139	159	non-cytoplasmic
160	180	transmembrane
181	191	cytoplasmic
192	210	transmembrane
211	232	non-cytoplasmic
233	254	transmembrane
255	265	cytoplasmic
266	290	transmembrane
291	311	non-cytoplasmic
312	336	transmembrane
337	365	cytoplasmic
366	384	transmembrane
385	389	non-cytoplasmic
390	410	transmembrane
411	421	cytoplasmic
422	442	transmembrane
443	447	non-cytoplasmic
448	467	transmembrane
468	474	cytoplasmic

Input:
>WP_036136365.1 NCBI__GCF_000768355.1:WP_036136365.1
MLQRLLATKHPHAAHADADGLSLHRTLGKWGLTALGIGAVIGGGIFVITGQAAADHAGPA
IMLSFVLAAICCTFCALAYAEFASMVPVSGSAYTYTYATLGELAAWFIGWMLVLEYGVSA
SAVAVSWTGYFLSLLEHFNIHLPAALVQAPLDSKLQPTGAIANLPAAAIVLLLTWVCYIG
IRKSSGMNTAMVLLKSGLIVLVIIAGWQYVDPANWEPFIPANEGPGKFGWEGVLRGASMV
FFAYIGFEAVSVAAQESHNPQKDLPFGMLMSLAICTVLYIGMAAVMTGLTPYTLLGTDEP
VVTAVAGHAELAWLRVVVEIGALIGLSSVVLVMIIGQPRIFMIMARDGLLPEVFTRIHPK
HRTPHINTVITGIGIALLAAVFPLDILGELTSMGTLIAFGAVCAGVLILRRTQPDLPRPF
RIRGVWFVCLAGIFSCLALLSAMTLHNWMLMLGWTTVGFAIYFLYGYRHSKLKG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server